This episode currently has no reviews.
Submit ReviewThe Food and Drug Administration is currently considering MDMA as a treatment for post-traumatic stress disorder. Anna Silman, features correspondent at Business Insider, breaks down her reporting on the decades-long fight to legalize the drug and why some pro-MDMA advocates are sounding the alarm.
The Food and Drug Administration is currently considering MDMA as a treatment for post-traumatic stress disorder. Anna Silman, features correspondent at Business Insider, breaks down her reporting on the decades-long fight to legalize the drug and why some pro-MDMA advocates are sounding the alarm.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review